Provigil

PreclinicalSmall molecule

Mylan Pharmaceuticals Inc

Provigil is one of 62 small molecule programs targeting Cocaine Dependence. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Cocaine DependenceActive, not recruiting

Combination TherapyUnknown status

Cocaine DependencePreclinical

Active, not recruiting

Combination TherapyPreclinical

Unknown status

Competition

Competitive Landscape

48 competitors in Combination Therapy

#DrugCompanyPhaseTrials

Oncovin

Eli Lilly

Approved

1 2

Avastin

Roche

Phase 2

5 3

Liposomal Doxorubicin

Eli Lilly

Phase 3

1 4

Keytruda

Merck & Co.

Phase 2

3 5

Taxol

Teva

Phase 2

3 6

Beyfortus

BeiGene

Phase 2

3 7

Braftovi

Pfizer

Phase 2

1 8

Cabometyx

Bristol-Myers Squibb

Phase 2

1 9

Abraxane

Bristol-Myers Squibb

Phase 2

1 10

Taxotere

AAvyxa

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Fatigue2 trials

Fatigue Treatment Using Provigil

Unknown status·SSheba Medical Center·N/A·NCT00220506·50 enrolled

Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue.

Completed·EEmory University·Phase 4·NCT00208715·100 enrolled

Cocaine Dependence1 trial

The Effects of Pharmacotherapy on Brain Mechanisms Underlying Cocaine Dependence.

Suspended·HHadassah Medical Organization·N/A·NCT00396734·40 enrolled

Concentration1 trial

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

Completed·CCephalon·Phase 3·NCT00236080·136 enrolled

Combination Therapy1 trial

Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS

Unknown status·IInstitute for Clinical Research·N/A·NCT00210301·60 enrolled

Unspecified2 trials

Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg

Completed· Mylan Pharmaceuticals Inc logo

Mylan Pharmaceuticals Inc·Phase 1·NCT00650000·32 enrolled

Food Study of Modafinil Tablets 200 mg to Provigil® Tablets 200 mg

Completed· Mylan Pharmaceuticals Inc logo

Mylan Pharmaceuticals Inc·Phase 1·NCT00650286·20 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for Provigil. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Provigil compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Provigil. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Mylan Pharmaceuticals Inc company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Mylan Pharmaceuticals Inc

Provigil

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Fatigue2 trials

Cocaine Dependence1 trial

Concentration1 trial

Combination Therapy1 trial

Unspecified2 trials

References

Drug Info

Quick Facts

Related News